Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data

**Background:** Cervical intraepithelial neoplasia (CIN) can be a consequence of human papillomavirus (HPV) infection. High-grade CIN (CIN2/CIN3) may develop from persistent HPV infection and progress to cervical cancer if left untreated. Management of CIN includes conservative surveillance or ablat...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna-Janina Stephan, Miriam Reuschenbach, Kunal Saxena, Vimalanand S. Prabhu, Christian Jacob, Kim M. Schneider, Wolfgang Greiner, Regine Wölle, Monika Hampl
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2022-05-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/001c.35329
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860290836496384
author Anna-Janina Stephan
Miriam Reuschenbach
Kunal Saxena
Vimalanand S. Prabhu
Christian Jacob
Kim M. Schneider
Wolfgang Greiner
Regine Wölle
Monika Hampl
author_facet Anna-Janina Stephan
Miriam Reuschenbach
Kunal Saxena
Vimalanand S. Prabhu
Christian Jacob
Kim M. Schneider
Wolfgang Greiner
Regine Wölle
Monika Hampl
author_sort Anna-Janina Stephan
collection DOAJ
description **Background:** Cervical intraepithelial neoplasia (CIN) can be a consequence of human papillomavirus (HPV) infection. High-grade CIN (CIN2/CIN3) may develop from persistent HPV infection and progress to cervical cancer if left untreated. Management of CIN includes conservative surveillance or ablation and excision by conization. Internationally, CIN and its treatment generate a considerable economic burden, but no current data regarding costs and resource use from the perspective of the German statutory health insurance exist. **Objectives:** The aim of this study was to explore the health economic burden in women with CIN diagnoses who either underwent cervical conization or were managed conservatively. **Methods:** We conducted a retrospective claims data analysis using the InGef Research Database from 2013 to 2018. Healthcare costs and resource utilization in a 24-month observation period (1:1:1 matching) were compared in 18- to 45-year-old women with CIN (1-3) who underwent a conization procedure (study cohort 1) and in women with CIN (1-3) who did not undergo conization (study cohort 2) to women with neither CIN nor conization (control group). **Results:** For each group, 2749 women were identified. Mean total healthcare costs after 24 months were higher in study cohort 1 (€4446, _P_<.01) and study cohort 2 (€3754, _P_=.09) compared with the control group (€3426). Comparing study cohort 1 and 2 to controls, mean differences were highest in age groups 41-45 years (cohort 1: €5115 vs €3354, _P_<.01; cohort 2: €4152 vs €3354, _P_=.14). Significantly more women were hospitalized at least once in study cohort 1 (57.46%, _P_<.01) and study cohort 2 (38.74%, _P_<.01) compared with the control group (31.14%). Frequency of outpatient physician visits was significantly higher in both study cohorts (43.23 visits, P<.01 and 38.60 visits, _P_<.01) compared with the control group (32.07 visits). **Conclusion:** Our results revealed 30% and 10% increased total healthcare costs in women with CIN undergoing invasive treatment (study cohort 1) and conservative management (study cohort 2), respectively, compared with a control group of women with no CIN in a 2-year follow-up period.
format Article
id doaj-art-7a55e16d11d241ff8d1c7082976fc58c
institution Kabale University
issn 2327-2236
language English
publishDate 2022-05-01
publisher Columbia Data Analytics, LLC
record_format Article
series Journal of Health Economics and Outcomes Research
spelling doaj-art-7a55e16d11d241ff8d1c7082976fc58c2025-02-10T16:13:13ZengColumbia Data Analytics, LLCJournal of Health Economics and Outcomes Research2327-22362022-05-0191Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims DataAnna-Janina StephanMiriam ReuschenbachKunal SaxenaVimalanand S. PrabhuChristian JacobKim M. SchneiderWolfgang GreinerRegine WölleMonika Hampl**Background:** Cervical intraepithelial neoplasia (CIN) can be a consequence of human papillomavirus (HPV) infection. High-grade CIN (CIN2/CIN3) may develop from persistent HPV infection and progress to cervical cancer if left untreated. Management of CIN includes conservative surveillance or ablation and excision by conization. Internationally, CIN and its treatment generate a considerable economic burden, but no current data regarding costs and resource use from the perspective of the German statutory health insurance exist. **Objectives:** The aim of this study was to explore the health economic burden in women with CIN diagnoses who either underwent cervical conization or were managed conservatively. **Methods:** We conducted a retrospective claims data analysis using the InGef Research Database from 2013 to 2018. Healthcare costs and resource utilization in a 24-month observation period (1:1:1 matching) were compared in 18- to 45-year-old women with CIN (1-3) who underwent a conization procedure (study cohort 1) and in women with CIN (1-3) who did not undergo conization (study cohort 2) to women with neither CIN nor conization (control group). **Results:** For each group, 2749 women were identified. Mean total healthcare costs after 24 months were higher in study cohort 1 (€4446, _P_<.01) and study cohort 2 (€3754, _P_=.09) compared with the control group (€3426). Comparing study cohort 1 and 2 to controls, mean differences were highest in age groups 41-45 years (cohort 1: €5115 vs €3354, _P_<.01; cohort 2: €4152 vs €3354, _P_=.14). Significantly more women were hospitalized at least once in study cohort 1 (57.46%, _P_<.01) and study cohort 2 (38.74%, _P_<.01) compared with the control group (31.14%). Frequency of outpatient physician visits was significantly higher in both study cohorts (43.23 visits, P<.01 and 38.60 visits, _P_<.01) compared with the control group (32.07 visits). **Conclusion:** Our results revealed 30% and 10% increased total healthcare costs in women with CIN undergoing invasive treatment (study cohort 1) and conservative management (study cohort 2), respectively, compared with a control group of women with no CIN in a 2-year follow-up period.https://doi.org/10.36469/001c.35329
spellingShingle Anna-Janina Stephan
Miriam Reuschenbach
Kunal Saxena
Vimalanand S. Prabhu
Christian Jacob
Kim M. Schneider
Wolfgang Greiner
Regine Wölle
Monika Hampl
Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data
Journal of Health Economics and Outcomes Research
title Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data
title_full Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data
title_fullStr Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data
title_full_unstemmed Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data
title_short Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data
title_sort healthcare costs and resource use associated with cervical intraepithelial neoplasia and cervical conization a retrospective study of german statutory health insurance claims data
url https://doi.org/10.36469/001c.35329
work_keys_str_mv AT annajaninastephan healthcarecostsandresourceuseassociatedwithcervicalintraepithelialneoplasiaandcervicalconizationaretrospectivestudyofgermanstatutoryhealthinsuranceclaimsdata
AT miriamreuschenbach healthcarecostsandresourceuseassociatedwithcervicalintraepithelialneoplasiaandcervicalconizationaretrospectivestudyofgermanstatutoryhealthinsuranceclaimsdata
AT kunalsaxena healthcarecostsandresourceuseassociatedwithcervicalintraepithelialneoplasiaandcervicalconizationaretrospectivestudyofgermanstatutoryhealthinsuranceclaimsdata
AT vimalanandsprabhu healthcarecostsandresourceuseassociatedwithcervicalintraepithelialneoplasiaandcervicalconizationaretrospectivestudyofgermanstatutoryhealthinsuranceclaimsdata
AT christianjacob healthcarecostsandresourceuseassociatedwithcervicalintraepithelialneoplasiaandcervicalconizationaretrospectivestudyofgermanstatutoryhealthinsuranceclaimsdata
AT kimmschneider healthcarecostsandresourceuseassociatedwithcervicalintraepithelialneoplasiaandcervicalconizationaretrospectivestudyofgermanstatutoryhealthinsuranceclaimsdata
AT wolfganggreiner healthcarecostsandresourceuseassociatedwithcervicalintraepithelialneoplasiaandcervicalconizationaretrospectivestudyofgermanstatutoryhealthinsuranceclaimsdata
AT reginewolle healthcarecostsandresourceuseassociatedwithcervicalintraepithelialneoplasiaandcervicalconizationaretrospectivestudyofgermanstatutoryhealthinsuranceclaimsdata
AT monikahampl healthcarecostsandresourceuseassociatedwithcervicalintraepithelialneoplasiaandcervicalconizationaretrospectivestudyofgermanstatutoryhealthinsuranceclaimsdata